Pages that link to "Q37073624"
Jump to navigation
Jump to search
The following pages link to HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses (Q37073624):
Displaying 50 items.
- The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis (Q26771181) (← links)
- HDAC inhibitors and immunotherapy; a double edged sword? (Q26853102) (← links)
- Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells (Q27015931) (← links)
- Beyond the genome: epigenetic mechanisms in lung remodeling (Q27021767) (← links)
- New and emerging HDAC inhibitors for cancer treatment (Q27022413) (← links)
- Mass spectrometric identification of ancient proteins as potential molecular biomarkers for a 2000-year-old osteogenic sarcoma (Q28539210) (← links)
- Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data (Q30936712) (← links)
- Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics. (Q33425333) (← links)
- Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy (Q33584050) (← links)
- B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB. (Q33597695) (← links)
- The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer (Q33659166) (← links)
- PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo (Q34199935) (← links)
- Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide (Q34318242) (← links)
- Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors (Q34413200) (← links)
- Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents (Q35214924) (← links)
- Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy (Q35497704) (← links)
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma. (Q35677697) (← links)
- Targeting Histone Deacetylases in Diseases: Where Are We? (Q35821728) (← links)
- Microarray gene expression profiling reveals potential mechanisms of tumor suppression by the class I HDAC-selective benzoylhydrazide inhibitors. (Q35884595) (← links)
- The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin (Q35890561) (← links)
- A genome scale RNAi screen identifies GLI1 as a novel gene regulating vorinostat sensitivity. (Q35921565) (← links)
- IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor (Q35933129) (← links)
- Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis (Q36256343) (← links)
- Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma (Q36316518) (← links)
- Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling (Q36356381) (← links)
- Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation (Q36414193) (← links)
- Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib (Q36782473) (← links)
- Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma (Q37078946) (← links)
- Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells. (Q37368670) (← links)
- Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer. (Q37613829) (← links)
- Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. (Q37684405) (← links)
- APPL proteins modulate DNA repair and radiation survival of pancreatic carcinoma cells by regulating ATM. (Q37726159) (← links)
- Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer (Q37737611) (← links)
- Epigenetics in esophageal cancers. (Q38210930) (← links)
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders (Q38240733) (← links)
- Selective class IIa HDAC inhibitors: myth or reality (Q38246144) (← links)
- Targeting chromatin to improve radiation response (Q38290243) (← links)
- Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy (Q38537768) (← links)
- Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results (Q38582589) (← links)
- Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma. (Q38735639) (← links)
- Induction of apoptosis by HBI-8000 in adult T-cell leukemia/lymphoma is associated with activation of Bim and NLRP3. (Q38770098) (← links)
- Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model (Q38791113) (← links)
- Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies (Q38811147) (← links)
- How do tumor cells respond to HDAC inhibition? (Q38817005) (← links)
- Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine (Q38881033) (← links)
- HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma (Q38918235) (← links)
- AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis (Q39058012) (← links)
- Functional differentiation of cytotoxic cancer drugs and targeted cancer therapeutics (Q39171471) (← links)
- Sulforaphane Reverses the Expression of Various Tumor Suppressor Genes by Targeting DNMT3B and HDAC1 in Human Cervical Cancer Cells (Q40751870) (← links)
- Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer (Q41517649) (← links)